SCHEMBL9900211

SCHEMBL9900211

CC(C)(C)OC(=O)N(c1cncc(Cl)n1)C1CCNCC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 5/20 0.32
SLC6A4 P31645 3/20 0.32
EHMT2 Q96KQ7 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
HTR1A P08908 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
QPCT Q16769 1/20 0.31
REN P00797 1/20 0.31
PARP1 P09874 1/20 0.31
SLC6A2 P23975 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9901214 0.87 KCNH2 (0.42) SLC6A4PARP1SLC6A2SLC6A3RPLP1
SCHEMBL9900118 0.84 GPR119 (0.31)
SCHEMBL5739332 0.81 EHMT2 (0.35) TACR1SLC6A4EHMT2MEN1KMT2A
SCHEMBL5738826 0.80 NOS2 (0.33) TACR1SLC6A4EHMT2SLC6A2SLC6A3
SCHEMBL4252888 0.79 EHMT2 (0.34) TACR1SLC6A4EHMT2MEN1KMT2A
SCHEMBL9900276 0.79 SLC6A4 (0.32) SLC6A4SLC6A2SLC6A3KCNH2
SCHEMBL9901287 0.78 POLB (0.39) TACR1SLC6A4EHMT2SLC6A2SLC6A3
SCHEMBL6826820 0.76 SYK (0.35) KMT2A
SCHEMBL16597711 0.75 NOS2 (0.39) TACR1SLC6A4SLC6A2SLC6A3
SCHEMBL3937268 0.75 PLAT (0.36) TACR1SLC6A4EHMT2HTR2CPLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2649065-A1 BICYCLIC COMPOUNDS AS PIM INHIBITORS Amgen Inc. (US) 2013-10-16 EP disclosed
WO-2012078777-A1 BICYCLIC COMPOUNDS AS PIM INHIBITORS AMGEN INC. (US) 2012-06-14 WO disclosed